These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24476439)

  • 21. [nab-Paclitaxel as new therapeutic option for pancreatic cancer].
    Michl P
    Z Gastroenterol; 2013 Nov; 51(11):1329-30. PubMed ID: 24243574
    [No Abstract]   [Full Text] [Related]  

  • 22. Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance.
    Cullen JJ; Spitz DR; Buettner GR
    Free Radic Biol Med; 2011 Jun; 50(12):1726-7. PubMed ID: 21459141
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.
    Masuda S; Koizumi K; Moriya H; Nishino T; Uojima H; Tazawa T; Kimura K; Tasaki J; Ichita C; Sasaki A; Kako M; Hidaka S; Kudo M
    Intern Med; 2021 Jan; 60(2):251-257. PubMed ID: 32963158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging new predictive biomarkers in metastatic breast cancer: Caveolin-1 and weekly nab-paclitaxel plus gemcitabine, are we on for tomorrow?
    Ricci F; Le Tourneau C
    Chin Clin Oncol; 2019 Oct; 8(S1):S14. PubMed ID: 30823843
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting B cells in pancreatic adenocarcinoma: does RESOLVE resolve the question?
    Philip PA
    Ann Oncol; 2021 May; 32(5):582-583. PubMed ID: 33607222
    [No Abstract]   [Full Text] [Related]  

  • 26. AACR highlights: promise for treating pancreatic cancer.
    Jenks S
    J Natl Cancer Inst; 2011 May; 103(10):786-7. PubMed ID: 21551418
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy for pancreatic cancer: the rise of multidrug regimens.
    Malka D; Borbath I; Conroy T
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):659-660. PubMed ID: 30215353
    [No Abstract]   [Full Text] [Related]  

  • 28. PEGPH20 May Improve Standard-of-Care Therapy in Pancreatic Cancer.
    Cancer Discov; 2018 Feb; 8(2):136. PubMed ID: 29269345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic cancer combo treatment promising.
    Health News; 2005 Aug; 11(8):2. PubMed ID: 16189852
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.
    Alvarez R; Musteanu M; Garcia-Garcia E; Lopez-Casas PP; Megias D; Guerra C; Muñoz M; Quijano Y; Cubillo A; Rodriguez-Pascual J; Plaza C; de Vicente E; Prados S; Tabernero S; Barbacid M; Lopez-Rios F; Hidalgo M
    Br J Cancer; 2014 Oct; 111(8):1677-8. PubMed ID: 24642623
    [No Abstract]   [Full Text] [Related]  

  • 31. Single agent paclitaxel in the treatment of unresectable and/or metastatic pancreatic adenocarcinoma.
    Gebbia N; Gebbia V
    Eur J Cancer; 1996 Sep; 32A(10):1822-3. PubMed ID: 8983300
    [No Abstract]   [Full Text] [Related]  

  • 32. The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505.
    Evans DB
    Ann Surg; 2020 Sep; 272(3):487. PubMed ID: 32657915
    [No Abstract]   [Full Text] [Related]  

  • 33. Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.
    Abad A; Masuti B; Camps C; Font A; Balañá C; Vicent JM; Sánchez JJ
    Eur J Cancer; 1994; 30A(7):1043. PubMed ID: 7946573
    [No Abstract]   [Full Text] [Related]  

  • 34. Charging forward in locally advanced pancreatic cancer.
    Segar J; Shroff RT
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):234-236. PubMed ID: 31953078
    [No Abstract]   [Full Text] [Related]  

  • 35. Leuprolide and tamoxifen in the treatment of pancreatic cancer. A phase II study.
    Zaniboni A; Meriggi F; Arcangeli G; Alghisi A; Huscher C; Marini G
    Eur J Cancer; 1994; 30A(1):128. PubMed ID: 8142155
    [No Abstract]   [Full Text] [Related]  

  • 36. Pancreatic cancer: how can we progress?
    Casper ES
    Eur J Cancer; 1993; 29A(2):171-2. PubMed ID: 8422277
    [No Abstract]   [Full Text] [Related]  

  • 37. Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult.
    Boeck S; Haas M; Ormanns S; Kruger S; Siveke JT; Heinemann V
    Br J Cancer; 2014 Oct; 111(8):1675-6. PubMed ID: 24642615
    [No Abstract]   [Full Text] [Related]  

  • 38. Stellate cells, a point of light in the dark night of pancreatic cancer.
    Ramírez N; Viúdez A; Hernández-García I; Guerrero D; Gómez-Dorronsoro M; Herrera FJ; Vila J; Beloki L; Ciaúrriz M; Mansilla C; Vera R
    Br J Cancer; 2014 Oct; 111(8):1676-7. PubMed ID: 24642614
    [No Abstract]   [Full Text] [Related]  

  • 39. Research trend of albumin-bound paclitaxel for the treatment of lung cancer: A 20-year investigation.
    Wang L; Zhao G; Fang H; Deng P
    Asian J Surg; 2024 Apr; 47(4):2091-2092. PubMed ID: 38242788
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to I. Pecora et al.
    Macarulla T; Hidalgo M
    J Clin Oncol; 2019 Aug; 37(22):1979. PubMed ID: 31188724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.